<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03447158</url>
  </required_header>
  <id_info>
    <org_study_id>18MMHIS001</org_study_id>
    <nct_id>NCT03447158</nct_id>
  </id_info>
  <brief_title>Effects of Sonographically Guided Subacromial Bursa Injection With Hyperosmolar Dextrose in Chronic Subacromial Bursitis</brief_title>
  <official_title>Effects of Sonographically Guided Subacromial Bursa Injection With Hyperosmolar Dextrose in Chronic Subacromial Bursitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mackay Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mackay Memorial Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main purpose of this study is to compare treatment efficacy of different concentration
      dextrose injection in chronic subacromial bursitis .
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 1, 2018</start_date>
  <completion_date type="Anticipated">March 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline visual analog scale (VAS) at 1 month after 3rd section of therapy</measure>
    <time_frame>before therapy sections and 1 month after third section of therapy</time_frame>
    <description>maximal VAS in the past week during movement, maximal VAS in the past week during resting, VAS during passive range of motion (PROM) in abduction &amp; flexion and during empty can test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline VAS at 3 months after 3rd section of therapy</measure>
    <time_frame>before therapy sections and 3 months after third section of therapy</time_frame>
    <description>maximal VAS in the past week during movement, maximal VAS in the past week during resting, VAS during passive range of motion (PROM) in abduction &amp; flexion and during empty can test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline VAS at moment after 3rd section of therapy</measure>
    <time_frame>before therapy sections and immediately after third section of therapy</time_frame>
    <description>maximal VAS in the past week during movement, maximal VAS in the past week during resting, VAS during passive range of motion (PROM) in abduction &amp; flexion and during empty can test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>shoulder joint passive range of motion (PROM)</measure>
    <time_frame>before therapy sections, immediately, 1 month after, and 3 months after 3rd section of therapy</time_frame>
    <description>abduction and flexion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Shoulder Pain and Disability Index (SPADI) score</measure>
    <time_frame>before therapy sections, immediately, 1 month after, and 3 months after 3rd section of therapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ultrasound property</measure>
    <time_frame>before therapy sections, immediately, 1 month after, and 3 months after 3rd section of therapy</time_frame>
    <description>Thickness of bursa and elastogram</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Subacromial Bursitis</condition>
  <arm_group>
    <arm_group_label>15% Dextrose group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>15% Dextrose</intervention_name>
    <description>inject 15% dextrose and xylocaine into subacrominal bursa under sonographically guidance</description>
    <arm_group_label>15% Dextrose group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Normal saline</intervention_name>
    <description>inject normal saline and xylocaine into subacrominal bursa under sonographically guidance</description>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. 20-65 years-old

          2. pain lasting &gt;3 months

          3. Painful arc between 40° to 120° in abduction

          4. positive Neer and Hawkins-Kennedy tests

          5. positive Empty can test

          6. pain in daily living activities

          7. Bursa thickness more than 2mm in ultrasound

        Exclusion Criteria:

          1. history of significant shoulder trauma

          2. history of surgery, fracture, or dislocation

          3. adhesive capsulitis

          4. full thickness rotator cuff tear

          5. a long head of bicep tendon tear

          6. Contra-indications to local dextrose injection (known blood coagulation disorders,
             warfarin therapy, allergy to dextrose)

          7. previous shoulder steroid injection in one month

          8. had any rheumatologic, systemic, or neurologic disorders

          9. patients taking regular systemic NSAIDs or steroids

         10. pregnant or breastfeeding mothers

         11. malignancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 14, 2018</study_first_submitted>
  <study_first_submitted_qc>February 25, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 27, 2018</study_first_posted>
  <last_update_submitted>March 26, 2018</last_update_submitted>
  <last_update_submitted_qc>March 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bursitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

